STERIS EBITDA Margin 2012-2025 | STE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for STERIS (STE) over the last 10 years. The current EBITDA margin for STERIS as of September 30, 2025 is .
| STERIS EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $5.70B | $1.46B | 25.64% |
| 2025-06-30 | $5.57B | $1.41B | 25.29% |
| 2025-03-31 | $5.46B | $1.34B | 24.57% |
| 2024-12-31 | $5.40B | $1.36B | 25.17% |
| 2024-09-30 | $5.33B | $1.36B | 25.54% |
| 2024-06-30 | $5.24B | $1.37B | 26.15% |
| 2024-03-31 | $5.14B | $1.41B | 27.38% |
| 2023-12-31 | $4.68B | $1.46B | 31.12% |
| 2023-09-30 | $4.60B | $1.41B | 30.74% |
| 2023-06-30 | $4.56B | $1.39B | 30.48% |
| 2023-03-31 | $4.54B | $1.35B | 29.81% |
| 2022-12-31 | $4.42B | $1.31B | 29.51% |
| 2022-09-30 | $4.42B | $1.30B | 29.40% |
| 2022-06-30 | $4.41B | $1.30B | 29.40% |
| 2022-03-31 | $4.22B | $1.10B | 26.00% |
| 2021-12-31 | $4.25B | $0.94B | 22.20% |
| 2021-09-30 | $3.85B | $0.83B | 21.44% |
| 2021-06-30 | $3.41B | $0.70B | 20.58% |
| 2021-03-31 | $3.11B | $0.77B | 24.71% |
| 2020-12-31 | $3.06B | $0.77B | 25.32% |
| 2020-09-30 | $3.02B | $0.76B | 25.22% |
| 2020-06-30 | $3.00B | $0.74B | 24.71% |
| 2020-03-31 | $3.03B | $0.73B | 24.22% |
| 2019-12-31 | $2.98B | $0.72B | 24.06% |
| 2019-09-30 | $2.90B | $0.68B | 23.33% |
| 2019-06-30 | $2.84B | $0.65B | 22.99% |
| 2019-03-31 | $2.78B | $0.64B | 22.90% |
| 2018-12-31 | $2.73B | $0.60B | 22.09% |
| 2018-09-30 | $2.70B | $0.60B | 22.22% |
| 2018-06-30 | $2.65B | $0.59B | 22.26% |
| 2018-03-31 | $2.62B | $0.58B | 22.06% |
| 2017-12-31 | $2.59B | $0.53B | 20.54% |
| 2017-09-30 | $2.57B | $0.50B | 19.42% |
| 2017-06-30 | $2.58B | $0.48B | 18.40% |
| 2017-03-31 | $2.61B | $0.47B | 18.11% |
| 2016-12-31 | $2.62B | $0.52B | 19.65% |
| 2016-09-30 | $2.59B | $0.49B | 18.94% |
| 2016-06-30 | $2.44B | $0.42B | 17.11% |
| 2016-03-31 | $2.24B | $0.36B | 15.94% |
| 2015-12-31 | $2.05B | $0.30B | 14.38% |
| 2015-09-30 | $1.91B | $0.29B | 15.01% |
| 2015-06-30 | $1.88B | $0.32B | 17.09% |
| 2015-03-31 | $1.85B | $0.32B | 17.23% |
| 2014-12-31 | $1.81B | $0.31B | 17.03% |
| 2014-09-30 | $1.75B | $0.30B | 17.23% |
| 2014-06-30 | $1.67B | $0.29B | 17.27% |
| 2014-03-31 | $1.62B | $0.28B | 17.38% |
| 2013-12-31 | $1.59B | $0.29B | 18.16% |
| 2013-09-30 | $1.56B | $0.30B | 19.10% |
| 2013-06-30 | $1.53B | $0.31B | 20.10% |
| 2013-03-31 | $1.50B | $0.31B | 20.79% |
| 2012-12-31 | $1.46B | $0.32B | 21.67% |
| 2012-09-30 | $1.44B | $0.30B | 21.00% |
| 2012-06-30 | $1.43B | $0.29B | 20.14% |
| 2012-03-31 | $1.41B | $0.29B | 20.26% |
| 2011-12-31 | $1.40B | $0.27B | 19.07% |
| 2011-09-30 | $1.37B | $0.25B | 17.91% |
| 2011-06-30 | $1.34B | $0.25B | 18.70% |
| 2011-03-31 | $1.21B | $0.14B | 11.52% |
| 2010-12-31 | $1.16B | $0.13B | 11.46% |
| 2010-09-30 | $1.16B | $0.16B | 13.61% |
| 2010-06-30 | $1.16B | $0.15B | 13.24% |
| 2010-03-31 | $1.26B | $0.26B | 20.75% |
| 2009-12-31 | $1.27B | $0.26B | 20.31% |
| 2009-09-30 | $1.26B | $0.25B | 19.59% |
| 2009-06-30 | $1.27B | $0.24B | 19.21% |
| 2009-03-31 | $1.30B | $0.24B | 18.26% |
| 2008-12-31 | $1.33B | $0.24B | 18.36% |
| 2008-09-30 | $1.32B | $0.23B | 17.45% |
| 2008-06-30 | $1.30B | $0.21B | 16.44% |
| 2008-03-31 | $1.27B | $0.20B | 15.97% |
| 2007-12-31 | $1.24B | $0.20B | 16.21% |
| 2007-09-30 | $1.23B | $0.20B | 16.57% |
| 2007-06-30 | $1.21B | $0.20B | 16.64% |
| 2007-03-31 | $1.20B | $0.20B | 17.03% |
| 2006-12-31 | $1.18B | $0.20B | 16.54% |
| 2006-09-30 | $1.17B | $0.20B | 16.80% |
| 2006-06-30 | $1.16B | $0.19B | 16.78% |
| 2006-03-31 | $1.16B | $0.19B | 16.65% |
| 2005-12-31 | $1.12B | $0.19B | 17.11% |
| 2005-09-30 | $1.10B | $0.19B | 17.23% |
| 2005-06-30 | $1.10B | $0.19B | 17.63% |
| 2005-03-31 | $1.08B | $0.19B | 17.84% |
| 2004-12-31 | $1.04B | $0.18B | 17.39% |
| 2004-09-30 | $1.04B | $0.18B | 17.20% |
| 2004-06-30 | $1.03B | $0.18B | 17.53% |
| 2004-03-31 | $1.03B | $0.18B | 17.26% |
| 2003-12-31 | $1.06B | $0.19B | 17.58% |
| 2003-09-30 | $1.03B | $0.18B | 17.60% |
| 2003-06-30 | $1.01B | $0.18B | 17.62% |
| 2003-03-31 | $0.97B | $0.17B | 17.70% |
| 2002-12-31 | $0.94B | $0.16B | 16.97% |
| 2002-09-30 | $0.92B | $0.15B | 16.34% |
| 2002-06-30 | $0.89B | $0.14B | 15.49% |
| 2002-03-31 | $0.87B | $0.13B | 14.76% |
| 2001-12-31 | $0.84B | $0.08B | 9.51% |
| 2001-09-30 | $0.83B | $0.08B | 9.44% |
| 2001-06-30 | $0.81B | $0.08B | 9.35% |
| 2001-03-31 | $0.80B | $0.07B | 8.88% |
| 2000-12-31 | $0.77B | $0.05B | 6.74% |
| 2000-09-30 | $0.76B | $0.05B | 6.43% |
| 2000-06-30 | $0.77B | $0.06B | 7.55% |
| 2000-03-31 | $0.76B | $0.07B | 9.07% |
| 1999-12-31 | $0.80B | $0.14B | 17.79% |
| 1999-09-30 | $0.81B | $0.16B | 19.78% |
| 1999-06-30 | $0.80B | $0.17B | 20.60% |
| 1999-03-31 | $0.80B | $0.17B | 21.30% |
| 1998-12-31 | $0.78B | $0.17B | 21.26% |
| 1998-09-30 | $0.76B | $0.16B | 20.48% |
| 1998-06-30 | $0.74B | $0.15B | 19.62% |
| 1998-03-31 | $0.72B | $0.14B | 18.89% |
| 1997-12-31 | $0.69B | $0.12B | 18.10% |
| 1997-09-30 | $0.65B | $0.11B | 17.26% |
| 1997-06-30 | $0.61B | $0.10B | 16.94% |
| 1997-03-31 | $0.59B | $0.10B | 17.21% |
| 1996-12-31 | $0.44B | $0.08B | 17.61% |
| 1996-09-30 | $0.32B | $0.06B | 18.35% |
| 1996-06-30 | $0.31B | $0.15B | 48.39% |
| 1996-03-31 | $0.20B | $0.13B | 65.84% |
| 1995-12-31 | $0.20B | $0.13B | 65.82% |
| 1995-09-30 | $0.19B | $0.13B | 67.20% |
| 1995-06-30 | $0.07B | $0.02B | 20.83% |
| 1995-03-31 | $0.07B | $0.01B | 21.54% |
| 1994-12-31 | $0.06B | $0.01B | 22.03% |
| 1994-09-30 | $0.05B | $0.01B | 20.37% |
| 1994-06-30 | $0.05B | $0.01B | 20.41% |
| 1994-03-31 | $0.05B | $0.01B | 17.78% |
| 1993-12-31 | $0.04B | $0.01B | 15.00% |
| 1993-09-30 | $0.04B | $0.01B | 14.29% |
| 1993-06-30 | $0.03B | $0.00B | 9.68% |
| 1993-03-31 | $0.03B | $0.00B | 7.41% |
| 1992-12-31 | $0.02B | $0.01B | 26.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $26.329B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.686B | 27.89 |
| Intuitive Surgical (ISRG) | United States | $194.058B | 75.92 |
| IDEXX Laboratories (IDXX) | United States | $56.864B | 56.47 |
| Edwards Lifesciences (EW) | United States | $49.030B | 32.88 |
| IQVIA Holdings (IQV) | United States | $41.090B | 22.91 |
| Alcon (ALC) | Switzerland | $39.297B | 26.56 |
| Mettler-Toledo (MTD) | United States | $30.573B | 35.77 |
| DexCom (DXCM) | United States | $27.005B | 37.23 |
| Waters (WAT) | United States | $23.497B | 31.07 |
| Coloplast (CLPBY) | Denmark | $20.013B | 34.15 |
| Hologic (HOLX) | United States | $16.722B | 17.57 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.356B | 0.00 |
| Penumbra (PEN) | United States | $13.726B | 96.55 |
| Globus Medical (GMED) | United States | $12.566B | 26.37 |
| Masimo (MASI) | United States | $7.513B | 24.07 |
| Glaukos (GKOS) | United States | $6.575B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.270B | 19.92 |
| TransMedics (TMDX) | United States | $4.911B | 58.17 |
| Teleflex (TFX) | United States | $4.623B | 7.37 |
| LivaNova (LIVN) | United Kingdom | $3.451B | 18.64 |
| Veracyte (VCYT) | United States | $3.241B | 36.94 |
| Integer Holdings (ITGR) | United States | $2.988B | 14.03 |
| Alphatec Holdings (ATEC) | United States | $2.594B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.051B | 94.11 |
| UFP Technologies (UFPT) | United States | $1.985B | 26.21 |
| Nihon Kohden (NHNKY) | Japan | $1.954B | 17.06 |
| PROCEPT BioRobotics (PRCT) | United States | $1.704B | 0.00 |
| AxoGen (AXGN) | United States | $1.440B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.429B | 0.00 |
| IRadimed (IRMD) | United States | $1.305B | 62.16 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.34 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.956B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.783B | 0.00 |
| SiBone (SIBN) | United States | $0.763B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.709B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.60 |
| Alpha Tau Medical (DRTS) | Israel | $0.651B | 0.00 |
| NeuroPace (NPCE) | United States | $0.578B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.485B | 13.40 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.454B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 60.06 |
| Sight Sciences (SGHT) | United States | $0.349B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.201B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.175B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.169B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.144B | 0.00 |
| CVRx (CVRX) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Solana (HSDT) | United States | $0.128B | 0.00 |
| Neuronetics (STIM) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| DarioHealth (DRIO) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.40 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |